Novartis CEO, Activism in Match, Boeing Latest 01/09/24

Brent Saunders, Chairman and CEO of Bausch + Lomb, shares insights on the future of eye care innovation. He highlights the company's launch of a new drug for dry eye disease and the ongoing challenges related to supply chain issues. Saunders discusses the alarming rise of myopia in children linked to screen time and emphasizes the importance of outdoor activity. Additionally, he reflects on Bausch's strategic separation from Bausch Health and the promising growth in the iHealth market.